Heart Disease News and Research

Latest Heart Disease News and Research

Commercial cholesterol measurement techniques produce mixed results: Study

The National Cholesterol Education Program maintains guidelines to assess the accuracy of methods for measuring cholesterol levels in patients. A recent study published in the journal Clinical Chemistry found that seven leading commercial methods produce results of mixed accuracy when compared to well-established techniques.

14 Jul 2010

Eban-based HIV/STD risk-reduction intervention improves safe-sex habits among high-risk African-American couples

A new study has found that heterosexual African American couples in which only one partner is HIV-positive practiced safer sexual behaviors after participating in a culturally specific intervention program designed to reduce the risk of HIV and other sexually transmitted diseases.

14 Jul 2010

New biological scaffolds will provide off-the-shelf tissue transplants

Professor John Fisher from The University of Leeds is speaking today (14 July) at the UK National Stem Cell Network Annual Science Meeting in Nottingham about his team's research into how biological scaffolding will pave the way for off- the-shelf tissue transplants.

14 Jul 2010

IAS announces recipients of CNIHR grants

The International AIDS Society today announced the recipients of its first joint research grant programme, Creative and Novel Ideas in HIV Research. CNIHR grants, funded in partnership with the U.S. National Institutes of Health and the NIH-supported Centers for AIDS Research are designed to promote innovative research and new ideas from early stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/ AIDS.

14 Jul 2010

Exposure to cigarette smoke can alter gene expression, study finds

In the largest study of its kind, researchers at the Southwest Foundation for Biomedical Research have found that exposure to cigarette smoke can alter gene expression -- the process by which a gene's information is converted into the structures and functions of a cell. These alterations in response to smoking appear to have a wide-ranging negative influence on the immune system, and a strong involvement in processes related to cancer, cell death and metabolism.

14 Jul 2010

Loyola primary care physicians honored with Blue Ribbon rating from Blue Cross and Blue Shield

Loyola University Health System primary care physicians recently received a Blue Ribbon rating from Blue Cross and Blue Shield. This honor is given to physicians who have received a satisfaction rate of 85 percent or higher based on a member survey.

14 Jul 2010

Individual genes and networks that play an important role in inflammation, atherosclerosis identified

HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.

14 Jul 2010

Palmetto Health Board of Directors approve establishment of Palmetto Health Quality Collaborative

The Palmetto Health Board of Directors has unanimously approved the establishment of Palmetto Health Quality Collaborative, LLC, often referred to as an accountable care organization. The Quality Collaborative will be a physician-led, patient-centered, interdependent medical entity that focuses on best practices in clinical outcomes and evidence-based care. Palmetto Health will soon begin offering the more than 1,000 physicians on its medical staff an opportunity to join.

14 Jul 2010

Researchers awarded $3M grant to establish DC D-CFAR

Researchers from institutions across Washington, DC, led by Alan E. Greenberg, M.D., M.P.H., of The George Washington University School of Public Health and Health Services, have been awarded an approximately $3M grant over five years from the National Institutes of Health to establish the District of Columbia Developmental Center for AIDS Research.

14 Jul 2010

UMMC receives $26M to identify risk factors for Alzheimer's disease

The University of Mississippi Medical Center and four collaborating academic medical centers have received $26 million from the National Institutes of Health to identify risk factors for Alzheimer's disease and related forms of cognitive decline, said Dr. Thomas Mosley, UMMC professor of geriatric medicine and one of the new study's lead investigators.

14 Jul 2010

InQ Biosciences to launch fully integrated Cell Research System

InQ Biosciences, a provider of innovative technologies for cell growth and research, announced its plans to launch the InQ™ Cell Research System during the fourth quarter of 2010. InQ is the first fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and other mammalian cells for disease research.

14 Jul 2010

Stimulation of single whisker prevents stroke in rats

Talk about surviving by a whisker. The most common type of stroke can be completely prevented in rats by stimulating a single whisker, according to a new study by UC Irvine researchers.

14 Jul 2010

FDA opens two-day hearing to examine safety of diabetes drug Avandia

The Fiscal Times: "There will be more at stake than just one drug's future when the Food and Drug Administration opens a two-day hearing Tuesday on the safety of the diabetes drug Avandia. The 30-member panel of outside experts will also be rendering judgment on research methods that are frequently used to compare effectiveness and are slated to become a pillar of the nation's drug safety monitoring system.

14 Jul 2010

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders

Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, "5-Lipoxygenase Activating Protein (FLAP) Inhibitors," which includes coverage of Amira's AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.

14 Jul 2010

LSUHSC Professor awarded $2.1M grant to determine role of PCP

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to determine the role and identify which T-helper cells fight the opportunistic infection, Pneumocystis carinii pneumonia, which can be a complication of HIV/AIDS.

14 Jul 2010

New research shows Alzheimer's disease may increase risk of other potentially disabling health conditions

Having Alzheimer's disease may increase the risk of getting other potentially disabling health conditions, including seizures and anemia, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, HI.

14 Jul 2010

Predictors of an Asian diabetes epidemic: A study

Experts believe diabetes will be the leading disease in Asia mainly because of the rise in consumption of junk and high calorie foods in this region of the world.

13 Jul 2010

FDA to decide on Avandia’s fate Wednesday

Avandia, a drug used as a treatment for type 2 diabetes was approved for use in 1999. However controversies have surrounded it since 2007 when a Cleveland Clinic cardiologist Steven E. Nissen published a study in the acclaimed New England Journal of Medicine that concluded that the drug significantly increased the risk for heart problems like heart attacks, heart failure and deaths.

13 Jul 2010

Combined behavioral interventions most effective way to reduce heart disease risk

Combining counseling, extended follow-up with a healthcare provider and self-monitoring of diet and exercise is the most effective way to help patients embrace lifestyle changes that can lower their risk for heart and blood vessel (cardiovascular) diseases, according to a scientific statement published in Circulation: Journal of the American Heart Association.

13 Jul 2010

Stereotaxis reports new capital orders of $10.2M in second-quarter 2010

Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.

13 Jul 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Commercial cholesterol measurement techniques produce mixed results: Study

Eban-based HIV/STD risk-reduction intervention improves safe-sex habits among high-risk African-American couples

New biological scaffolds will provide off-the-shelf tissue transplants

IAS announces recipients of CNIHR grants

Exposure to cigarette smoke can alter gene expression, study finds

Loyola primary care physicians honored with Blue Ribbon rating from Blue Cross and Blue Shield

Individual genes and networks that play an important role in inflammation, atherosclerosis identified

Palmetto Health Board of Directors approve establishment of Palmetto Health Quality Collaborative

Researchers awarded $3M grant to establish DC D-CFAR

UMMC receives $26M to identify risk factors for Alzheimer's disease

InQ Biosciences to launch fully integrated Cell Research System

Stimulation of single whisker prevents stroke in rats

FDA opens two-day hearing to examine safety of diabetes drug Avandia

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders

LSUHSC Professor awarded $2.1M grant to determine role of PCP

New research shows Alzheimer's disease may increase risk of other potentially disabling health conditions

Predictors of an Asian diabetes epidemic: A study

FDA to decide on Avandia’s fate Wednesday

Combined behavioral interventions most effective way to reduce heart disease risk

Stereotaxis reports new capital orders of $10.2M in second-quarter 2010

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in